Capreomycin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00314 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | rheumatoid arthritis | KG + DL |
| 3 | osteoarthritis | KG + DL |
| 4 | osteoarthritis susceptibility | KG + DL |
| 5 | sclerosing cholangitis | KG + DL |
| 6 | brachydactyly-syndactyly syndrome | KG + DL |
| 7 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 8 | meningococcal infection | KG + DL |
| 9 | pseudoachondroplasia | KG + DL |
| 10 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 11 | brachyolmia | KG + DL |
| 12 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 13 | myosclerosis | KG + DL |
| 14 | infectious otitis media | KG + DL |
| 15 | arthropathy | KG + DL |
| 16 | suppurative cholangitis | KG + DL |
| 17 | congestive heart failure | KG + DL |
| 18 | middle ear cholesterol granuloma | KG + DL |
| 19 | otosalpingitis | KG + DL |
| 20 | middle ear disease | KG + DL |
| 21 | chronic otitis media | KG + DL |
| 22 | non-suppurative otitis media | KG + DL |
| 23 | allergic otitis media | KG + DL |
| 24 | paratyphoid fever | KG + DL |
| 25 | suppurative otitis media | KG + DL |
| 26 | peritonitis | KG + DL |
| 27 | acute pulmonary heart disease | KG + DL |
| 28 | paratenonitis | KG + DL |
| 29 | myositis | KG + DL |
| 30 | bacterial arthritis | KG + DL |
| 31 | calcific tendinitis | KG + DL |
| 32 | epiglottitis | KG + DL |
| 33 | WHIM syndrome | KG + DL |
| 34 | Lyme disease | KG + DL |
| 35 | chronic pulmonary heart disease | KG + DL |
| 36 | IgG4-related pachymeningitis | KG + DL |
| 37 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 38 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 39 | IgG4-related sclerosing cholangitis | KG + DL |
| 40 | diabetic nephropathy | KG + DL |
| 41 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 42 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 43 | malignant hypertensive renal disease | KG + DL |
| 44 | malignant renovascular hypertension | KG + DL |
| 45 | hypertensive disorder | KG + DL |
| 46 | cholangitis | KG + DL |
| 47 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 48 | Schnitzler syndrome | KG + DL |
| 49 | Braddock syndrome | KG + DL |
| 50 | staphylococcus aureus infection | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.